EchoGo Amyloidosis vs PMcardio
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Both tools leverage AI for cardiac diagnostics, but they focus on different modalities and conditions. EchoGo Amyloidosis analyzes echocardiogram video clips specifically for the early detection of cardiac amyloidosis, while PMcardio interprets ECGs to assess over 50 cardiac conditions, including STEMI and arrhythmias. Therefore, they are adjacent rather than direct competitors, as their primary input data and specific diagnostic targets differ.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGo Amyloidosis is designed for seamless integration with existing clinical workflows and IT infrastructure, including PACS, DICOM, and HL7, returning findings directly into existing clinical systems. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, aiming for one integration and one security review for system-wide cardiac care.
EchoGo Amyloidosis has a high diagnostic accuracy with 85% sensitivity and 93% specificity for cardiac amyloidosis, performing consistently across different subtypes. PMcardio's Core AI ECG Model demonstrates 86% sensitivity and 92% specificity for major ECG abnormalities, and its Queen of Heartsu2122 model for STEMI detection has shown 92% sensitivity and 81% specificity, outperforming standard processes.
EchoGo Amyloidosis is specifically designed for cardiology, aiding in the early detection of cardiac amyloidosis from echocardiogram video clips, particularly in adults aged 65 and older with heart failure. PMcardio is suitable for a broader range of specialties including cardiology, emergency medicine, and internal medicine, providing instant AI-powered ECG interpretations for over 50 cardiac conditions, including STEMI/OMI and reduced LVEF.
EchoGo Amyloidosis integrates into routine echocardiography workflows without requiring additional steps, suggesting a low learning curve and rapid time-to-value as findings are returned directly into existing systems. PMcardio aims to deliver rapid, expert-level interpretations in seconds, empowering various healthcare professionals to act with confidence at the point of care, which implies a quick time-to-value.
PMcardio for Organizations includes full audit trails for every pathway action, and the Pro Plan for individuals offers a detailed ECG report history for documentation and audits.